When blood is not an option: Optimal bloodless management of severe anemia in pregnancy
dc.contributor.author | Zurales, Katherine R. | |
dc.contributor.author | Janke, Monica | |
dc.contributor.author | Carver, Alissa R. | |
dc.contributor.author | Napolitano, Lena M. | |
dc.date.accessioned | 2022-11-09T21:18:59Z | |
dc.date.available | 2023-12-09 16:18:58 | en |
dc.date.available | 2022-11-09T21:18:59Z | |
dc.date.issued | 2022-11 | |
dc.identifier.citation | Zurales, Katherine R.; Janke, Monica; Carver, Alissa R.; Napolitano, Lena M. (2022). "When blood is not an option: Optimal bloodless management of severe anemia in pregnancy." Journal of Obstetrics and Gynaecology Research 48(11): 2968-2972. | |
dc.identifier.issn | 1341-8076 | |
dc.identifier.issn | 1447-0756 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/175104 | |
dc.description.abstract | Standard treatment for severe anemia in pregnancy is allogeneic blood transfusion, but this is not acceptable to all patients. Options for alternative anemia treatment are available. In this case report, a 32-year-old G2P1 woman who was a Jehovah’s Witness presented at 27 weeks gestation with dyspnea, palpitations, and severe anemia (hemoglobin 2.8 g/dL) related to chronic rectal bleeding. She declined blood transfusion. An anemia management protocol (high-dose erythropoietin-stimulating agent, iron, vitamin D, vitamin C, folate, vitamin B12) rapidly increased endogenous erythropoiesis. After 12 days, hemoglobin increased to 8 g/dL. A bovine hemoglobin-based oxygen carrier was available for acute bleeding but was not used. This case highlights that early initiation of multimodal therapy can adequately increase endogenous erythropoiesis to treat life-threatening anemia in antepartum patients who do not accept blood transfusion. | |
dc.publisher | John Wiley & Sons Australia, Ltd | |
dc.subject.other | erythropoiesis | |
dc.subject.other | hemoglobin | |
dc.subject.other | pregnancy | |
dc.subject.other | anemia | |
dc.subject.other | bloodless medical and surgical procedures | |
dc.title | When blood is not an option: Optimal bloodless management of severe anemia in pregnancy | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Obstetrics and Gynecology | |
dc.subject.hlbsecondlevel | Pediatrics | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/175104/1/jog15384_am.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/175104/2/jog15384.pdf | |
dc.identifier.doi | 10.1111/jog.15384 | |
dc.identifier.source | Journal of Obstetrics and Gynaecology Research | |
dc.identifier.citedreference | Belfort M, Kofford S, Varner M. Massive obstetric hemorrhage in a Jehovah’s Witness: intraoperative strategies and high-dose erythropoietin use. Am J Perinatol. 2011; 28: 207 – 10. | |
dc.identifier.citedreference | Tanaka M, Matsuzaki S, Endo M, Kakigano A, Mimura K, Takiuchi T, et al. Obstetric outcomes and acceptance of alternative therapies to blood transfusion by Jehovah’s Witnesses in Japan: a single-center study. Int J Hematol. 2018; 108: 432 – 7. | |
dc.identifier.citedreference | Koenig HM, Levine EA, Resnick DJ, Meyer WJ. Use of recombinant human erythropoietin in a Jehovah’s Witness. J Clin Anesth. 1993; 5: 244 – 7. | |
dc.identifier.citedreference | Chae C, Okocha O, Sweitzer B. Preoperative considerations for Jehovah’s Witness patients: a clinical guide. Curr Opin Anaesthesiol. 2020; 33: 432 – 40. | |
dc.identifier.citedreference | Posluszny JA Jr, Napolitano LM. How do we treat life-threatening anemia in a Jehovah’s Witness patient? Transfusion. 2014; 54: 3026 – 34. | |
dc.identifier.citedreference | Zeybek B, Childress AM, Kilic GS, Phelps JY, Pacheco LD, Carter MA, et al. Management of the Jehovah’s Witness in obstetrics and gynecology: a comprehensive medical, ethical, and legal approach. Obstet Gynecol Surv. 2016; 71: 488 – 500. | |
dc.identifier.citedreference | Van Wolfswinkel ME, Zwart JJ, Schutte JM, Duvekot JJ, Pel M, Van Roosmalen J. Maternal mortality and serious maternal morbidity in Jehovah’s witnesses in The Netherlands. BJOG. 2009; 116: 1103 – 8. discussion 1108-1110. | |
dc.identifier.citedreference | Smith EM, Jones JL, Han JE, Alvarez JA, Sloan JH, Konrad RJ, et al. High-dose vitamin D3 administration is associated with increases in hemoglobin concentrations in mechanically ventilated critically ill adults: a pilot double-blind, randomized, placebo-controlled trial. JPEN J Parenter Enteral Nutr. 2018; 42: 87 – 94. | |
dc.identifier.citedreference | Smith EM, Alvarez JA, Kearns MD, Hao L, Sloan JH, Konrad RJ, et al. High-dose vitamin D3 reduces circulating hepcidin concentrations: a pilot, randomized, double-blind, placebo-controlled trial in healthy adults. Clin Nutr. 2017; 36: 980 – 5. | |
dc.identifier.citedreference | Napolitano LM. Vitamin D supplementation and hemoglobin: dosing matters in prevention/treatment of anemia. Nutr J. 2021; 20: 23. | |
dc.identifier.citedreference | Mytinger AK, Sheehan E, Blue N, Crookston K, Saeed AI. Management of life threatening post-partum hemorrhage with HBOC-201 in a Jehovah’s Witness. Southwest J Pulm Crit Care. 2017; 14: 177 – 84. | |
dc.identifier.citedreference | Hashida T, Nakada T, Takahashi W, Abe R, Oda S. Extremely severe anaemia in a critically ill patient who declined a blood transfusion. Transfus Med. 2015; 25: 195 – 7. | |
dc.identifier.citedreference | Rasanayagam SR, Cooper GM. Two cases of severe postpartum anaemia in Jehovah’s witnesses. Int J Obstet Anesth. 1996; 5: 202 – 5. | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.